Guinea-Bissau suspends Trump-backed hepatitis B vaccine study for ethical review
Guinea-Bissau is suspending a Trump administration-backed hepatitis B vaccine study on newborns in the West African country, pending an ethical review, the health minister said Thursday.
Guinea-Bissau suspends Trump-backed hepatitis B vaccine study for ethical review Guinea-Bissau has announced the suspension of a hepatitis B vaccine study involving newborns. The study was reportedly backed by the Trump administration. The suspension is in effect pending a thorough ethical review of the research.
- Guinea-Bissau is suspending a hepatitis B vaccine study on newborns.
- The study was backed by the Trump administration.
- The suspension is due to an ongoing ethical review.
No comments yet.
Write a comment